🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06822218
Recruiting Not applicable

High Tone Power Therapy Versus Transcutanuoselectrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients

NCT06822218 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2023-01-01
Last updated
2025-02-12

Condition(s) studied

Diabete Mellitus

Investigational drug(s) / intervention(s)

high tone power therapyTENS

high tone power therapy: patients will be assigned into 2 groups with pre and post treatment protocol application. all patients will be thoroughly evaluated before and after treatment protocol application.

TENS: These patients will receive TENS with applied frequencies range from 2 to 120 Hz. for 3 times per week for 30 minutes every session during 3 months of intervention in addition to medications.

Study summary

the results of this study may provide an easy non pharmacological modality for dealing with diabetic polyneuropathic pain. Also, the outcome of this study will guide physiotherapists to develop a new noninvasive treatment modality that may improve patient symptoms and promotes their social participation , this in turn may add to clinical role played by therapists in management of diabetic polyneuropathy. In Addition, increased knowledge of the influence of High tone power therapy on neuropathic pain

Eligibility

Sex
MALE
Min age
50 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * The patient selection will be according to the following criteria: 1. Sixty male patients are diagnosed with diabetic polyneuropathy their ages will be ranged from 50-60 years old. 2. All patients are ambulant independently. 3. All patients are under full medical control 4. HbA1c is ranged from 6.5 : 7 %. 5. Patients has diabetes more than 10 years. Exclusion Criteria: * The participants will be excluded if they meet one of the following criteria: 1. Psychiatric disorders or seizures. 2. Visual and auditory impairment or tremors influencing balance. 3. Other neuromuscular disorders. 4. Foot deformities and ulcers. 5. Lower limb operations. 6. Feverish systemic infection 7. cardiac pacemaker.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Om Elmasryeen Genral Hospital Giza Egypt Recruiting

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06822218 on ClinicalTrials.gov ↗ ← All trials in Egypt